4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-009972
10% owner sold 160,964 shares at an average $30.42 ($4,896,561)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morningside Venture Investments Ltd 10% owner | 2023-03-27 | Sale | −32,964 | $30.25 | $997,161 | 7,154,350 | D |
| Morningside Venture Investments Ltd 10% owner | 2023-03-27 | Sale | −28,000 | $30.80 | $862,400 | 7,126,350 | D |
| Morningside Venture Investments Ltd 10% owner | 2023-03-28 | Sale | −100,000 | $30.37 | $3,037,000 | 7,026,350 | D |
| Open-market sales · 160,964 sh · avg $30.42 · $4,896,561 | |||||||
Loading xslF345X04/doc4.xml…